circumstances. Cautious optimism for the future of the clinical Victoria 3053, Australia application of this technology has been expressed (Tucker 1 To whom correspondence should be addressed et al., 1998a) ; these authors have also demonstrated that cryopreservation of human immature oocytes with subsequent
This opinion was previously published on Webtrack 84, September 9, 1999 in-vitro maturation can be compatible with fertilization, pregnancy and live birth (Tucker et al., 1998b) . The potential advantages associated with the ability to freeze Two important issues, however, remain to be resolved before and store human oocytes successfully have been well estabthe role of this technology in current practice can be fully lished for some time. Not only would it allow the circumvention elucidated. Firstly, it would be preferable if continuing research of moral, ethical and legal problems which arise as an inevitable could determine whether modifications to the above method consequence of embryo freezing, but also it would offer the could improve outcome. A tendency to adopt techniques widely prospect of broadening the fertility options available to women when they show promise often occurs at the expense of further who, for a variety of medical reasons, are likely to lose ovarian refinement. For example, a recent study has suggested that function prematurely. Banks of frozen donated oocytes would optimal survival of human oocytes may be achieved at an icefacilitate the donation process, which is often complicated by seeding temperature which is higher than that used in current a requirement for donor-recipient synchrony. More controclinical oocyte cryopreservation protocols (Trad et al., 1998) . versially, oocyte storage would also open the door to the This is particularly important when we consider the second possibility of women, with no medical indications and no issue, which concerns the relative efficiency of oocyte and immediate plans to conceive, being able to store 'young eggs' embryo freezing. If we are to consider mature oocyte freezing for potential use at a later date.
as an alternative to embryo freezing then we need to be aware Technically, the possibility of offering oocyte cryopreservof the likely return from the available material in each case. ation as a routine procedure had seemed somewhat remote
In other words we need to ask 'How many implantations can after failure to reproduce early reports of success with a we expect per 100 fresh oocytes available?'. Figures from our dimethylsulphoxide-based method in the 1980s (Chen, 1986;  own unit suggest that~90% of collected oocytes may be Al-Hasani et al., 1987; Van Uem et al., 1987) . The difficulties expected to be mature, that ICSI would be expected to result encountered in achieving success with human mature (metain normal (dipronucleate) fertilization in~60% of injected phase II) oocytes were postulated to arise mainly from inherent mature oocytes, and that~90% of early cleavage stage (day problems associated with the susceptibility of the mammalian 2) embryos generated would be considered suitable for cryospindle to freezing induced damage. Such problems were preservation. This means that just under 50 embryos would highlighted by reports of elevated rates of post-thaw aneuploidy be frozen per 100 oocytes collected in a unit where embryo in cryopreserved mouse oocytes (Kola et al., 1988) . However, utilization/cryopreservation rates are high. Our post-thaw work by our group using propanediol and sucrose as cryoresults suggest that, although only 15% of all embryos frozen protectants in conjunction with a slow freeze/rapid thaw fail to survive cryopreservation, only 55% of frozen embryos method based on that successfully used for post-fertilization will survive with all blastomeres intact after thawing. The stages in the human, suggested that this pessimism was not percentage of fully intact thawed embryos which develop to justified. We showed that oocytes could survive cryopreservthe fetal heart (FH) stage following transfer in our unit is ation without compromising spindle integrity (Gook et al., ~1 2%, a figure which is almost double the value for embryos 1993), that post-thaw fertilization was characterized by normal which have suffered blastomere loss as a result of cryopreservkaryotypes and an absence of stray chromosomes (Gook ation . Taking all the above into account would result in an et al., 1994) , and that frozen/thawed oocytes fertilized by estimated four FHs per 100 collected oocytes subjected to the intracytoplasmic sperm injection (ICSI) could undergo normal process of in-vitro fertilization (IVF) and embryo cryopreservpreimplantation development (Gook et al., 1995) . This validation. While a more selective approach to the choice of ation of the feasibility of the method culminated in the first embryos for cryopreservation and for post-thaw transfer may reported live birth (Porcu et al., 1997) . Subsequent reports of series of pregnancies and live births (Borini et al., 1998; Porcu increase the apparent implantation rate, the overall attrition rate would remain unaltered. Although the application of applying the technology, the need to develop in-vitro methods mature oocyte cryopreservation is at an early stage, it would for human primordial follicle development and oocyte maturnot be unreasonable to expect that technical refinement and ation which result in oocytes which are suitable for IVF and more widespread adoption may result in a similar return. Early can demonstrate subsequent developmental competence. This clinical results (Borini et al., 1998; Porcu et al., 1998) suggest poses a significant challenge both at present and in the future. that this may be so although, for comparisons to be valid, all It has been stressed that hasty clinical application of this stages at which attrition occurs (i.e. pre-and post-freeze) must technology should be discouraged until the outcome of ongoing be included in the calculations for both processes.
clinical research trials is known (Gosden et al., 1999) . Even if, however, the technique does not fully match the Storage of human oocytes, either in the mature state or expectations from embryo cryopreservation it will be an as immature oocytes in follicles within ovarian tissue, will important option in cases where moral, ethical, religious and inevitably be subject to similar considerations as those applying even psychological issues are considered to be paramount.
to sperm storage. For example, the question of whether different We cannot accurately estimate the psychological effects on guidelines should apply to donated material or material individuals or couples of having surplus embryos in storage.
intended for an individual's own use has been raised. In the In many cases, disposal of such embryos may be a legal state of Victoria in Australia, legislation allows storage of requirement following an elapsed period of time thereby gametes for a maximum period of 10 years although extensions providing an additional dilemma. In addition, we may expect may be granted by the statutory body in response to applicathat the demand for oocyte freezing will grow in response to tions. Clinics and legislators will also be faced with decisions the trend towards deferring conception until later in the female on what action to take if a patient dies with oocytes/ovarian reproductive life.
tissue in storage, and whether such material can be used to It is for another group of patients, however, that the existing form embryos for transfer to a surrogate uterus. As the technology and its future development is of crucial importance.
technology moves forward the need to reach a consensus on The ability to detect many cancers at relatively early stages the above issues will become more urgent. and the use of aggressive cytotoxic therapy have greatly improved the long term survival prospects for many patients. Among them are young women who will be rendered infertile References by the loss of ovarian function which is a consequence of the Hum. Reprod., 14, 2061 -2068 some success in other species (Gosden et al., 1994; Candy Gook, D.A., Osborn, S.M., Bourne, H. and Johnston, W.I.H. (1994) Fertilization et al., 1995; Gunasena et al., 1997) and preliminary data on of human oocytes following cryopreservation; normal karyotypes and human tissue (Zhang et al., 1995; Newton et al., 1996 ; Hovatta absence of stray chromosomes. Hum. Reprod., 9, 684-691. et al., 1997; Oktay et al., 1997) in vitro or in vivo following thawing of the tissue. Considering Reprod., 12, [101] [102] [103] [104] [105] [106] the fact that much of the stored tissue is likely to be derived Hovatta, O., Silye, R., Abir, R. et al. (1997) Extracellular matrix improves survival of both stored and fresh human primordial and primary ovarian from patients with malignant disease, an earlier report (Shaw follicles in long-term culture. Hum. Reprod., 12, 1032 Reprod., 12, -1036 Reprod., 12, . et al., 1996 , which demonstrated the transmission of malignant Kola, I., Kirby, C., Shaw, J. et al. (1988) all, cases. This highlights the second important factor in
